$ENSC ripping premarket! 🚀 Up 53% 🔹 Ensysce Biosciences is a clinical-stage biotech developing next-gen pain medicines designed to reduce opioid abuse and ove

$ENSC ripping premarket! 🚀 Up 53% 🔹 Ensysce Biosciences is a clinical-stage biotech developing next-gen pain medicines designed to reduce opioid abuse and overdose risk 💊 🔹 Lead programs include PF614 and PF614-MPAR, using abuse-deterrent and overdose-protection technology 🧬 🔹 Recent catalyst:…